The Rhythmic Nature of Female Physiology June 23, 2026Janet Maendel Immune Signaling, Circadian Biology, and the Female Cancer Terrain Rhythmic Movement at Sunrise A woman’s biology moves through phases and transitions that influence nearly every system in the body...
Women Are Not Small Men June 16, 2026Janet Maendel Understanding the Rhythms, Strength, and Systems Biology of Female Physiology Modern medicine has historically studied women through a predominantly male physiologic lens. Yet women are not simply smaller versions of...
The Engine of Persistence: Why Mitochondrial Integrity is the Real Checkpoint May 16, 2026Janet Maendel Why a Trained Immune System Still Needs the Stamina to Finish the Fight In the world of immuno-oncology, we are obsessed with activation. But activation without persistence - the ability to...
The Resource War: Why You Can’t Fight a War on an Empty Stomach May 09, 2026Janet Maendel Shifting the Logistics of the Tumor Microenvironment to Empower Immune Competence We have spent decades trying to “awaken” the immune system to recognize cancer, but we’ve ignored the most basic...
Beyond the On-Switch: The Tactical Intelligence of Double Loaded Dendritic Cell Therapy (IDCT) May 02, 2026Janet Maendel Why a Precision Immune Strategy Requires a High-Functioning Metabolic Worksite In the current landscape of Immuno-Oncology, we are often sold the idea that simply "unleashing" the immune system is enough....
The Liver–Immune Axis: How Hepatic Function Determines Immune Response April 26, 2026Janet Maendel The liver is often described as a metabolic or detoxification organ, but clinically, it functions just as much as an immune organ. It sits at a critical intersection - receiving...
Tumor Visibility in Immuno-Oncology: The Problem of Recognition April 19, 2026Janet Maendel1 comment For the immune system to respond appropriately, it must be able to identify what is abnormal. This process depends on antigen presentation - tumor derived proteins that are processed and...
The Post Treatment Journey: Why Immunotherapy Outcomes may be Won or Lost after Treatment April 12, 2026Janet Maendel A patient undergoes treatment - immunotherapy, integrative immune therapies, dendritic cell therapy, or a combination of these - and the initial response is encouraging. Labs shift. The immune system learns...
In the Context of Immunity, Inflammation Is Not the Enemy April 06, 2026Janet Maendel A patient presents with elevated inflammatory markers, CRP, LDH, ferritin, ESR, and the immediate response is to suppress. Anti-inflammatory agents are introduced. Supplements are layered. In some cases, corticosteroids are...
Immune Readiness Is a Metabolic State April 04, 2026Janet Maendel We often speak about the immune system as though it were either capable or incapable, responsive or refractory, strong or weak. In clinical reality, immune readiness is rarely binary. It...
What Are Immune Checkpoints—And How Does Cancer Hijack Them? March 31, 2026Janet Maendel Immune checkpoints are often described as the body’s natural brakes. That is true, but it’s not the whole story. In oncology, the issue is not simply that checkpoints exist. The...
When the Immune System Lacks Instruction March 28, 2026Janet Maendel Immune systems do not fail because they are weak.They fail because they are confused. In cancer care, we often talk about immune activation as though it were the goal. Stimulate...